Ali Kakanejadifard
Ali Kakanejadifard publishes mostly in Organic Chemistry, Materials Chemistry and Molecular Biology, on topics such as Metal complexes synthesis and properties, Synthesis and Characterization of Heterocyclic Compounds and Synthesis and biological activity.
- World rank
- #4,476,351 of 7,710,434 ranked researchers
- Rank in Iran
- #33,019 of 71,317
- Works
- 137
- Citations
- 2.1k
- Citations per work
- 15.4
What does Ali Kakanejadifard research?
Ali Kakanejadifard's work is mostly in Chemistry (45%), Materials Science (10%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences7554.9%
- Chemistry6144.6%
- Materials Science1410.3%
- Everything else4633.7%
- Life Sciences86.1%
- Health Sciences75.3%
- Medicine75.3%
- 1Organic Chemistry35% of their works
- 2Materials Chemistry10% of their works
- 3Molecular Biology6% of their works
- 4Oncology5% of their works
- 5Physical and Theoretical Chemistry5% of their works
- 6Inorganic Chemistry4% of their works
Research topics
- Metal complexes synthesis and properties
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and biological activity
- Crystallography and molecular interactions
- Nanomaterials for catalytic reactions
- Synthesis and Biological Evaluation
- Catalytic Cross-Coupling Reactions
- Inorganic Fluorides and Related Compounds
Which keywords describe Ali Kakanejadifard's research?
The keywords of their largest research topics: Anticancer Agents, Biological Evaluation, Synthesis, Heterocyclic Compounds, Medicinal Chemistry, Cisplatin Resistance, Platinum-Based Drugs and Antimicrobial.
- Fluoride Ion Batteries
- Cross-Coupling Reactions
- Antimicrobial Activity
- Catalytic Reduction
- Molecular Crystals
- Tubulin Inhibitors
- Antimicrobial
- Cisplatin Resistance
- Heterocyclic Compounds
- Biological Evaluation
- Anticancer Agents
- Synthesis
- Medicinal Chemistry
- Platinum-Based Drugs
- Triazines
- Vascular Targeting Agents
- Noncovalent Interactions
- Nitro Compounds
- Quinoxaline
- Palladium-Catalyzed
- Noble Gas Compounds
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Anticancer Agents463 topics
- Biological Evaluation272 topics
- Synthesis272 topics
- Heterocyclic Compounds262 topics
- Medicinal Chemistry262 topics
- Cisplatin Resistance201 topic
- Platinum-Based Drugs201 topic
- Antimicrobial181 topic
- Triazines181 topic
- Tubulin Inhibitors171 topic
- Vascular Targeting Agents171 topic
- Molecular Crystals121 topic
- Noncovalent Interactions121 topic
- Catalytic Reduction101 topic
- Nitro Compounds101 topic
- Antimicrobial Activity91 topic
- Quinoxaline91 topic
- Cross-Coupling Reactions81 topic
- Palladium-Catalyzed81 topic
- Fluoride Ion Batteries71 topic
- Noble Gas Compounds71 topic
Where does Ali Kakanejadifard work?
Ali Kakanejadifard's main affiliation in the publication record is Lorestan University, Iran.
How many publications and citations does Ali Kakanejadifard have?
OpenAlex counts 137 works and 2,116 citations for Ali Kakanejadifard, an h-index of 23, ranking #4,476,351 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ali Kakanejadifard. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.